FDA Put Brakes On Penny Stock Kezar Life Sciences' Mid-Stage Study For Lead Development Candidate After Patient Deaths – Yahoo Finance
The FDA has halted a mid-stage study for Kezar Life Sciences’ lead development candidate following the deaths of patients.